Description:
See how today’s FDA-approved inhibitors are fighting angiogenesis, a condition in which rapid blood-vessel growth can indicate malignant tumors. What does the future hold for the next generation of this new class of drugs? Could cancer be detected earlier through the study of how angiogenesis inhibitors are transported in the body? Speaker(s):
Judah Folkman, M.D., surgeon & professor, Harvard Medical School
|
